Cas:87553-57-9 4-[[2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxobutanoyl]amino]benzenesulfonate,dimethyl(dioctadecyl)azanium manufacturer & supplier

Chemical Name:4-[[2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxobutanoyl]amino]benzenesulfonate,dimethyl(dioctadecyl)azanium

CAS.NO:87553-57-9

Synonyms:1-Octadecanaminium,N,N-dimethyl-N-octadecyl-,salt with 4-((2-((3,3′-dichloro-4′-((2-oxo-1-((phenylamino)carbonyl)propyl)azo)(1,1′-biphenyl)-4-yl)azo)-1,3-dioxobutyl)amino)benzenesulfonic acid (1:1)

Molecular Formula:C₇₀H₁₀₅Cl₂N₇O₇S

Molecular Weight:1259.60000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:210.85000

Exact Mass:1257.72000

LogP:22.52870

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-Octadecanaminium,N,N-dimethyl-N-octadecyl-,salt with 4-((2-((3,3′-dichloro-4′-((2-oxo-1-((phenylamino)carbonyl)propyl)azo)(1,1′-biphenyl)-4-yl)azo)-1,3-dioxobutyl)amino)benzenesulfonic acid (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Octadecanaminium,N,N-dimethyl-N-octadecyl-,salt with 4-((2-((3,3′-dichloro-4′-((2-oxo-1-((phenylamino)carbonyl)propyl)azo)(1,1′-biphenyl)-4-yl)azo)-1,3-dioxobutyl)amino)benzenesulfonic acid (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Octadecanaminium,N,N-dimethyl-N-octadecyl-,salt with 4-((2-((3,3′-dichloro-4′-((2-oxo-1-((phenylamino)carbonyl)propyl)azo)(1,1′-biphenyl)-4-yl)azo)-1,3-dioxobutyl)amino)benzenesulfonic acid (1:1) Use and application,1-Octadecanaminium,N,N-dimethyl-N-octadecyl-,salt with 4-((2-((3,3′-dichloro-4′-((2-oxo-1-((phenylamino)carbonyl)propyl)azo)(1,1′-biphenyl)-4-yl)azo)-1,3-dioxobutyl)amino)benzenesulfonic acid (1:1) technical grade,usp/ep/jp grade.

Related News: Orchard’s decision is suggestive of the difficulty drugmakers can face in turning complex, but promising rare disease treatments into a sustainable business. The termination wasn’t unexpected; Orchard said last May it was reducing staff and reordering its priorities, reducing investment in OTL-101 as a result. (S)-Perhydroazepine-2-carboxylic acid manufacturers Dan Wygal, Country President for AstraZeneca Ireland, said: “I want to congratulate Charles River on their exciting plans to expand their Ballina site. Charles River is a long-standing strategic partner to AstraZeneca and have provided us with critical support in response to the pandemic. 3-(3,5-difluorophenyl)-8-((3-methylbenzyl)amino)-8-azabicyclo[3.2.1]octane-3-carbonitrile suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 2H-Imidazo[4,5-b]pyridin-2-one, 6-bromo-1,3-dihydro-, hydrazone vendor & factory.